Plus Therapeutics (PSTV) EBIT (2011 - 2026)
Plus Therapeutics (PSTV) reported EBIT of -$7.1 million for Q1 2026, down 101.33% year-over-year from $535.6 million in Q1 2025, and down 23.98% quarter-over-quarter from -$5.7 million in Q4 2025.
Plus Therapeutics (PSTV) EBIT (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 16 years of EBIT data on file, last reported at -$7.1 million in Q1 2026.
- EBIT for Q1 2026 came in at -$7.1 million, down 101.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$18.9 million (down 26.45% YoY), and the FY2025 annual result was -$15.3 million, down 4.1% from the prior year.
- EBIT fell to -$7.1 million in Q1 2026 per PSTV's latest filing, from -$5.7 million in the prior quarter.
- Over five years, EBIT peaked at -$1.5 million in Q2 2023 and troughed at -$7.1 million in Q1 2026.
- A 5-year average of -$4.1 million and a median of -$3.9 million in 2024 frame the typical range for EBIT.
- The sharpest annual moves came in 2023 and 2024: EBIT surged 70.9% in 2023, then slumped 148.12% in 2024.
- A 5-year view of EBIT shows it stood at -$5.6 million in 2022, then jumped by 30.76% to -$3.9 million in 2023, then retreated by 1.09% to -$3.9 million in 2024, then slumped by 47.23% to -$5.7 million in 2025, then declined by 23.98% to -$7.1 million in 2026.
- Business Quant data shows PSTV's EBIT at -$7.1 million in Q1 2026, -$5.7 million in Q4 2025, and -$4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | -7.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.12 Mn |
| Dec 31, 2025 | -5.74 Mn |
| Sep 30, 2025 | -4.48 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Mar 31, 2025 | -3.54 Mn |
| Dec 31, 2024 | -3.90 Mn |
| Sep 30, 2024 | -3.80 Mn |
| Jun 30, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.30 Mn |
| Dec 31, 2023 | -3.86 Mn |
| Sep 30, 2023 | -3.25 Mn |
| Jun 30, 2023 | -1.49 Mn |
| Mar 31, 2023 | -4.72 Mn |
| Dec 31, 2022 | -5.57 Mn |
| Sep 30, 2022 | -5.09 Mn |
| Jun 30, 2022 | -5.12 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.94 Mn |
| Sep 30, 2021 | -3.50 Mn |
| Jun 30, 2021 | -2.58 Mn |